We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
NXS.AU

Price
0.10
Stock movement up
+- (%)
Company name
Next Science Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
29.22M
Ent value
30.40M
Price/Sales
0.87
Price/Book
4.13
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-4.82%
1 year return
-71.01%
3 year return
-50.51%
5 year return
-43.29%
10 year return
-
Last updated: 2025-04-05

DIVIDENDS

NXS.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.87
Price to Book4.13
EV to Sales0.90

FINANCIALS

Per share

Loading...
Per share data
Current share count292.16M
EPS (TTM)-0.08
FCF per share (TTM)-0.11

Income statement

Loading...
Income statement data
Revenue (TTM)33.77M
Gross profit (TTM)24.36M
Operating income (TTM)-22.08M
Net income (TTM)-22.30M
EPS (TTM)-0.08
EPS (1y forward)-0.02

Margins

Loading...
Margins data
Gross margin (TTM)72.14%
Operating margin (TTM)-65.40%
Profit margin (TTM)-66.03%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash3.57M
Net receivables3.23M
Total current assets8.18M
Goodwill0.00
Intangible assets-519.05K
Property, plant and equipment0.00
Total assets11.83M
Accounts payable3.11M
Short/Current long term debt825.06K
Total current liabilities3.77M
Total liabilities4.76M
Shareholder's equity7.07M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-24.46M
Capital expenditures (TTM)1.05M
Free cash flow (TTM)-33.52M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-315.46%
Return on Assets-188.56%
Return on Invested Capital-304.43%
Cash Return on Invested Capital-457.66%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.10
Daily high0.10
Daily low0.10
Daily Volume49K
All-time high4.60
1y analyst estimate0.35
Beta1.51
EPS (TTM)-0.08
Dividend per share-
Ex-div date-
Next earnings date2 May 2025

Downside potential

Loading...
Downside potential data
NXS.AUS&P500
Current price drop from All-time high-97.83%-17.56%
Highest price drop-97.83%-56.47%
Date of highest drop4 Apr 20259 Mar 2009
Avg drop from high-75.25%-11.07%
Avg time to new high116 days12 days
Max time to new high1470 days1805 days
COMPANY DETAILS
NXS.AU (Next Science Ltd) company logo
Marketcap
29.22M
Marketcap category
Small-cap
Description
Next Science Limited engages in the research, development, and commercialization of technologies that address the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial gel that conforms to the postoperative wound; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Sydney, Australia.
Employees
0
Investor relations
-
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found